FDA grants remdesivir emergency use authorization for COVID-19

By Erika Edwards The Food and Drug Administration has granted remdesivir emergency use authorization to treat the most severely ill COVID-19 patients. The FDA action specifies the drug may be used for both adults and children with suspected or confirmed COVID-19 diagnoses who are severely ill with low blood oxygen levels or who may be […]

Continue Reading